Pamela G. Marrone - 15 Sep 2021 Form 4 Insider Report for MARRONE BIO INNOVATIONS INC

Role
Director
Signature
/s/ Linda V. Moore, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Sep 2021
Net transactions value
+$24,000
Form type
4
Filing time
17 Sep 2021, 16:29:42 UTC
Previous filing
25 Aug 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBII Common Stock Options Exercise $24,000 +30,000 +1.4% $0.8000 2,238,363 15 Sep 2021 Direct
holding MBII Common Stock 6,442 15 Sep 2021 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBII Stock Option (Right to buy) Options Exercise $0 -30,000 -41% $0.000000 43,320 15 Sep 2021 Common Stock 30,000 $0.8000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
F2 The options vested with respect to 25% of the total shares subject to the option on the first anniversary of the vesting commencement date of August 11, 2016, and with respect to 1/48th of the total shares subject to the option monthly thereafter for 36 months.